Femasys (FEMY) Change in Receivables (2020 - 2026)
Femasys' (FEMY) quarterly Change in Receivables came in at -$444336.0 in Q1 2026, down 74.4% YoY from -$1.7 million in Q1 2025, and down 1100.73% on a QoQ basis from $44401.0 in Q4 2025.
Femasys (FEMY) Change in Receivables (2020 - 2026) Analysis & Trends
Femasys (FEMY) has 7 years of Change in Receivables data on file, last reported at -$444336.0 in Q1 2026.
- Quarterly Change in Receivables fell 74.4% year-over-year to -$444336.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$61334.0 (down 154.73% YoY) and the FY2025 annual result came in at $128227.0, down 67.08% from the prior year.
- Change in Receivables eased to -$444336.0 in Q1 2026, from $44401.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $317615.0 in Q3 2025 to a low of -$444336.0 in Q1 2026.
- A 5-year average of $5176.8 and a median of $22623.0 in 2024 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2024 — Change in Receivables surged 2467.38% — and 2025, when it sank 1226.18%.
- Tracing FEMY's Change in Receivables over 5 years: stood at -$105660.0 in 2022, then jumped by 95.6% to -$4650.0 in 2023, then surged by 2467.38% to $110083.0 in 2024, then plunged by 59.67% to $44401.0 in 2025, then slumped by 1100.73% to -$444336.0 in 2026.
- The last three Change in Receivables figures came in at -$444336.0 (Q1 2026), $44401.0 (Q4 2025), and $317615.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 74.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 37.21 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 252.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 156.00 Mn |
| 10 | Femasys | 9.97 Mn | 8.53 Mn | 189,391.00 | -21,215.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -444,336.00 |
| Mar 31, 2026 | -444,336.00 |
| Dec 31, 2025 | 44,401.00 |
| Dec 31, 2025 | 44,401.00 |
| Sep 30, 2025 | 317,615.00 |
| Sep 30, 2025 | 317,615.00 |
| Jun 30, 2025 | 20,986.00 |
| Jun 30, 2025 | 20,986.00 |
| Mar 31, 2025 | -254,775.00 |
| Mar 31, 2025 | -254,775.00 |
| Dec 31, 2024 | 110,083.00 |
| Dec 31, 2024 | 110,083.00 |
| Sep 30, 2024 | 285,755.00 |
| Sep 30, 2024 | 285,755.00 |
| Jun 30, 2024 | -28,994.00 |
| Jun 30, 2024 | -28,994.00 |
| Mar 31, 2024 | 22,623.00 |
| Mar 31, 2024 | 22,623.00 |
| Dec 31, 2023 | -4,650.00 |
| Dec 31, 2023 | -4,650.00 |